Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the orthobiologics market?

The market size of orthobiologics has significantly expanded in the recent past. It is projected to escalate from a value of $7.08 billion in 2024 to reach $7.56 billion in 2025, marking a compound annual growth rate (CAGR) of 6.7%. This considerable growth during the historical timeline can be credited to factors including a heightened occurrence of orthopedic illnesses and conditions, trend towards less invasive procedures, growth in reconstructive surgeries, and a surge in healthcare spending. Further, bolstering the growth was heightened awareness among patients and healthcare providers and the financial progress in the emerging markets.

What will be the orthobiologics market size in the future?

It is projected that the orthobiologics market will experience robust expansion in the coming years. By 2029, the market worth is expected to reach $9.7 billion, surging at a compound annual growth rate (CAGR) of 6.5%. Factors such as the increasing aging population and sedentary lifestyle trends, the continuous advancement of new products, favorable insurance policies, new product approvals in the orthobiologic sector, and the broadened use of existing orthobiologic products account for this growth. Key trends for the future include progress in regenerative medicine, product innovation, technological progression, strategic actions, and market broadening.

Get your orthobiologics market report here!

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

What main drivers are fueling expansion in the orthobiologics market?

The escalating frequency of vehicular mishaps and injuries resulting from sports activities are anticipated to spur the expansion of the orthobiologics market. These incidents, which result in physical injury often implicate the musculoskeletal system. Various factors seed these mishaps and injuries including distracted driving, soaring speed, poor road conditions, overuse of bodies or equipment in sports, incorrect gear and insufficient training. Orthobiologics facilitate treatment of such injuries and accidents, bolstering swift and efficient healing of musculoskeletal tissues. Additionally, they alleviate inflammation and augment natural healing mechanisms of the body through substances like bone grafts, growth stimulators, stem cells and platelet-rich plasma. For instance, Eurostat, the statistical arm of the European Union, reported that in March 2024, fatal road accidents caused 20653 deaths in Europe, surging from 3.7% compared to 19917 in 2021. Consequentially, the surge in sports-related injuries and road mishaps are projected to bolster the growth of the orthobiologics market.

What key areas define the segmentation of the global orthobiologics market?

The orthobiologics market covered in this report is segmented –

1) By Product Type: Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products

2) By Application: Spinal Fusion, Maxillofacial And Dental, Soft Tissue Repair, Reconstructive And Fracture Surgery, Other Applications

3) By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Viscosupplements: Hyaluronic Acid Injections, Gel-Based Viscosupplements, Cross-linked Hyaluronic Acid, Other Viscosupplement Products

2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs), Recombinant Human Bone Morphogenetic Proteins (rhBMPs), Platelet-Rich Plasma (PRP), Osteogenic Protein-1 (OP-1), Growth Factors For Bone Healing

3) By Demineralized Bone Matrix: DBM Grafts, DBM Putty, DBM Sponges, DBM Paste And Chips

4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes, Calcium Sulfate-Based Substitutes, Tricalcium Phosphate (TCP), Hydroxyapatite (HA), Bioactive Glasses, Other Synthetic Bone Substitutes

5) By Cellular Allograft: Osteocellular Allografts, Mesenchymal Stem Cells (MSCs) Allografts, Bone Marrow-Derived Cellular Allografts, Adipose Tissue-Derived Cellular Allografts

6) By Other Products: Autografts, Collagen-Based Grafts, Synthetic Bone Graft Substitutes (Non-Bioactive), Amniotic Membrane-Based Grafts, Exosome-Based Products, Other Miscellaneous Orthobiologic Products

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp

Who are the dominant players expanding their reach in the orthobiologics market?

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

What are the key trends shaping the future of the orthobiologics market?

Leading firms in the orthobiologics market are innovating new solutions like dry allograft mixtures to improve bone healing and fusion during orthopedic procedures. These mixtures pair strong cortical fibers with mineralized cortical bone, offering structural stability and fostering osteoinductive properties for new bone growth. For example, Isto Biologics, a biologics-centric company based in the US, introduced Fibrant Liberty allograft in May 2024. This dry allograft mixture utilizes durable cortical fibers and mineralized cortical cancellous chips. When hydrated, the graft gains flexibility and can be adjusted for a range of surgical procedures. The lengthier and sturdier fibers improve manipulation and create a complex network that checks graft movement while preserving structural solidity.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16139

Which regions are emerging as leaders in the orthobiologics market?

North America was the largest region in the orthobiologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Biologics Outsourcing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

Biologics Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Biologics CDMO Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: